PATENT CLAIM ANALYSIS

Application Number: 16179453
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["424", "001690"]

Abstract:
There is provided a radiolabelled peptide-based compound for diagnostic imaging using positron emission tomography (PET). The compound may thus be used for diagnosis of malignant diseases. The compound is particularly useful for imaging of somatostatin overexpression in tumors, wherein the compound is capable of being imaged by PET when administered with a target dose in the range of 150-350 MBq, such as 150-250 MBq, preferable in the range of 191-210 MBq.

Claim (Index 7):
The method of  claim 1 , wherein the radiographic imaging method is performed 3 hours after administration of the imaging composition.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 98.0
- Lexical Diversity: 1.49057
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14241958', '13447918', '13878689', '14983746', '14215879']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7013470602537086
- 35 USC 102 Novelty (BERT): 0.5788101746831504
- Combined Prediction Score: 0.6890933716966529
- Mean Citation Score: 223.967324
- Max Citation Score: 490.02512
- Similarity Product: 393.4163502320194

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test